PALI — Palisade Bio Inc · P/E 15, rev $500.0K

Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.

Latest reported PALI revenue for 2026-06-30 was $500.0K. Net income was -$20.2M. PALI currently screens at market cap $316.3M and trailing P/E 15.2.

Use this PALI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PALI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PALI SEC filings page. Lician reads the product cache first so this HTML stays unique to Palisade Bio Inc even when a live quote feed is slow.

Palisade Bio Inc latest statements (FY2025)

Latest cached year on this hub. Full PALI income, balance, and cash tables.

  • Revenue$0
  • Net Income-$16.8M
  • Total Assets$134.3M
  • Total Debt$0
  • Free Cash Flow$0